This inventor holds 1 USPTO granted patent. Top assignees: Novoheart International Limited, University of California. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: The Innovative Contributions of Eugene Lee
Introduction
Eugene Lee is a notable inventor based in Irvine, California. He has made significant contributions to the field of drug discovery and development through his innovative patent. His work focuses on predicting the mechanisms of activity of unknown drug candidate compounds, which has the potential to revolutionize the pharmaceutical industry.
Latest Patents
Eugene Lee holds a patent titled "Methods and apparatuses for prediction of mechanism of activity of compounds." This patent describes a platform designed to predict the type or family of an unknown drug candidate compound. The platform includes a living cell or tissue, a detector that measures cellular responses, and a memory that stores data related to these responses. The processing units are configured to analyze the data and compare it with a library of known drug types, allowing for predictions about the unknown drug's type, family, or mechanism of action.
Career Highlights
Eugene has worked with prestigious organizations, including the University of California and Novoheart International Limited. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Eugene has collaborated with notable individuals such as Michelle Khine and Tang Wai Ronald Adolphus Li. These partnerships have enhanced his research and development efforts, leading to innovative solutions in drug discovery.
Conclusion
Eugene Lee's work exemplifies the impact of innovation in the pharmaceutical industry. His patent and collaborations highlight his commitment to advancing drug discovery methods. Through his contributions, he continues to pave the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile